HROW
Price:
$46.77
Market Cap:
$1.73B
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office s...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2007-09-28
Stock Exchange
NASDAQ
Ticker
HROW
According to Harrow Health, Inc.’s latest financial reports and current stock price. The company's current ROE is -17.50%. This represents a change of 268.78% compared to the average of -4.75% of the last 4 quarters.
The mean historical ROE of Harrow Health, Inc. over the last ten years is 17.00%. The current -17.50% ROE has changed -202.95% with respect to the historical average. Over the past ten years (40 quarters), HROW's ROE was at its highest in in the December 2015 quarter at 369.96%. The ROE was at its lowest in in the March 2018 quarter at -4232.53%.
Average
17.00%
Median
-29.80%
Minimum
-458.32%
Maximum
1.15%
Discovering the peaks and valleys of Harrow Health, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.19%
Maximum Annual ROE = 1.15%
Minimum Annual Increase = -2137.03%
Minimum Annual ROE = -458.32%
| Year | ROE | Change |
|---|---|---|
| 2024 | -25.10% | -27.24% |
| 2023 | -34.50% | -32.42% |
| 2022 | -51.05% | -68.01% |
| 2021 | -159.55% | 1.19% |
| 2020 | -12.35% | -2137.03% |
| 2019 | 0.61% | -98.97% |
| 2018 | 59.09% | -112.89% |
| 2017 | -458.32% | 54.45% |
| 2016 | -296.75% | -125.85% |
| 2015 | 1.15% | -1024.68% |
The current ROE of Harrow Health, Inc. (HROW) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-36.88%
5-year avg
-56.51%
10-year avg
17.00%
Harrow Health, Inc.’s ROE is greater than Evotec SE (-16.91%), greater than Tilray Brands, Inc. (-96.86%), greater than Dynavax Technologies Corporation (-9.16%), less than Amphastar Pharmaceuticals, Inc. (14.80%), greater than BioLife Solutions, Inc. (-1.61%), less than Collegium Pharmaceutical, Inc. (24.09%), less than KESTRA MEDICAL TECHNOLOGIES, LTD. (289.25%), greater than Alvotech (-20.57%), greater than Trevi Therapeutics, Inc. (-31.23%), greater than Phreesia, Inc. (-8.75%),
| Company | ROE | Market cap |
|---|---|---|
| -16.91% | $1.15B | |
| -96.86% | $808.48M | |
| -9.16% | $1.29B | |
| 14.80% | $1.25B | |
| -1.61% | $1.24B | |
| 24.09% | $1.50B | |
| 289.25% | $1.26B | |
| -20.57% | $1.58B | |
| -31.23% | $1.73B | |
| -8.75% | $1.23B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Harrow Health, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Harrow Health, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Harrow Health, Inc.'s ROE?
How is the ROE calculated for Harrow Health, Inc. (HROW)?
What is the highest ROE for Harrow Health, Inc. (HROW)?
What is the 3-year average ROE for Harrow Health, Inc. (HROW)?
What is the 5-year average ROE for Harrow Health, Inc. (HROW)?
How does the current ROE for Harrow Health, Inc. (HROW) compare to its historical average?